WF Dolphin
Cambridge, CAR (UK)
Role(s):
C-Level Executive (CEO, CFO, etc.)
avita medical
Find More Startups
Startup
Location:
Cambridge
Industry:
Bio-Technology
Year Founded:
2003
Number Employees:
10-50 people
Description:
Regenerative Medicine
The company develops and distributes tissue-engineered products for the treatment of a wide range of wounds, scars and skin defects. Using proprietary tissue-culture/collection technology, the company is able to provide innovative treatment solutions derived from the patient’s own skin, to enhance healing rates, reduce scar formation and reintroduce pigmentation into the skin.
ReCell® ((URL removed)o) is a stand-alone, rapid cell harvesting device that enables surgeons to treat skin defects using the patient’s own cells that are collected during surgery. The surgeon can prepare a small quantity of cells within 30 minutes on site rather than having to send a biopsy to the laboratory. ReCell® has been designed for use in a wide variety of plastic, reconstructive and cosmetic procedures. ReCell® is gaining acceptance in a number of indications including Vitiligo, a common skin pigmentation disease.
ReCell® is approved for sale in Australia, Brazil, Canada, Chile, Croatia, European Union, Hong Kong, Israel, Japan, Malaysia, New Zealand, Norway, Singapore, South Africa, Switzerland and Turkey. The company is currently focused on securing FDA approval for sale of the product in the USA.